Broadly Neutralizing Activity of Zika Virus-Immune Sera Identifies a Single Viral Serotype

Kimberly A. Dowd; Christina R. DeMaso; Rebecca S. Pelc; Scott D. Speer; Alexander R.Y. Smith; Leslie Goo; Derek J. Platt; John R. Mascola; Barney S. Graham; Mark J. Mulligan; Michael S. Diamond; Julie E. Ledgerwood; Theodore C. Pierson

doi:10.1016/j.celrep.2016.07.049

Broadly Neutralizing Activity of Zika Virus-Immune Sera Identifies a Single Viral Serotype

Kimberly A. Dowd, Christina R. DeMaso, Rebecca S. Pelc, Scott D. Speer, Alexander R.Y. Smith, Leslie Goo, Derek J. Platt, John R. Mascola, Barney S. Graham, Mark J. Mulligan, Michael S. Diamond, Julie E. Ledgerwood, Theodore C. Pierson

Research output: Contribution to journal › Article › peer-review

176 Scopus citations

Abstract

Recent epidemics of Zika virus (ZIKV) have been associated with congenital malformation during pregnancy and Guillain-Barré syndrome. There are two ZIKV lineages (African and Asian) that share >95% amino acid identity. Little is known regarding the ability of neutralizing antibodies elicited against one lineage to protect against the other. We investigated the breadth of the neutralizing antibody response following ZIKV infection by measuring the sensitivity of six ZIKV strains to neutralization by ZIKV-confirmed convalescent human serum or plasma samples. Contemporary Asian and early African ZIKV strains were similarly sensitive to neutralization regardless of the cellular source of virus. Furthermore, mouse immune serum generated after infection with African or Asian ZIKV strains was capable of neutralizing homologous and heterologous ZIKV strains equivalently. Because our study only defines a single ZIKV serotype, vaccine candidates eliciting robust neutralizing antibody responses should inhibit infection of both ZIKV lineages, including strains circulating in the Americas.

Original language	English
Pages (from-to)	1485-1491
Number of pages	7
Journal	Cell Reports
Volume	16
Issue number	6
DOIs	https://doi.org/10.1016/j.celrep.2016.07.049
State	Published - Aug 9 2016

Access to Document

10.1016/j.celrep.2016.07.049

Cite this

Dowd, K. A., DeMaso, C. R., Pelc, R. S., Speer, S. D., Smith, A. R. Y., Goo, L., Platt, D. J., Mascola, J. R., Graham, B. S., Mulligan, M. J., Diamond, M. S., Ledgerwood, J. E., & Pierson, T. C. (2016). Broadly Neutralizing Activity of Zika Virus-Immune Sera Identifies a Single Viral Serotype. Cell Reports, 16(6), 1485-1491. https://doi.org/10.1016/j.celrep.2016.07.049

@article{93dfb281bef442d6977493ee5cbb15c3,

title = "Broadly Neutralizing Activity of Zika Virus-Immune Sera Identifies a Single Viral Serotype",

abstract = "Recent epidemics of Zika virus (ZIKV) have been associated with congenital malformation during pregnancy and Guillain-Barr{\'e} syndrome. There are two ZIKV lineages (African and Asian) that share >95% amino acid identity. Little is known regarding the ability of neutralizing antibodies elicited against one lineage to protect against the other. We investigated the breadth of the neutralizing antibody response following ZIKV infection by measuring the sensitivity of six ZIKV strains to neutralization by ZIKV-confirmed convalescent human serum or plasma samples. Contemporary Asian and early African ZIKV strains were similarly sensitive to neutralization regardless of the cellular source of virus. Furthermore, mouse immune serum generated after infection with African or Asian ZIKV strains was capable of neutralizing homologous and heterologous ZIKV strains equivalently. Because our study only defines a single ZIKV serotype, vaccine candidates eliciting robust neutralizing antibody responses should inhibit infection of both ZIKV lineages, including strains circulating in the Americas.",

author = "Dowd, {Kimberly A.} and DeMaso, {Christina R.} and Pelc, {Rebecca S.} and Speer, {Scott D.} and Smith, {Alexander R.Y.} and Leslie Goo and Platt, {Derek J.} and Mascola, {John R.} and Graham, {Barney S.} and Mulligan, {Mark J.} and Diamond, {Michael S.} and Ledgerwood, {Julie E.} and Pierson, {Theodore C.}",

note = "Publisher Copyright: {\textcopyright} 2016",

year = "2016",

month = aug,

day = "9",

doi = "10.1016/j.celrep.2016.07.049",

language = "English",

volume = "16",

pages = "1485--1491",

journal = "Cell Reports",

issn = "2211-1247",

number = "6",

}

TY - JOUR

T1 - Broadly Neutralizing Activity of Zika Virus-Immune Sera Identifies a Single Viral Serotype

AU - Dowd, Kimberly A.

AU - DeMaso, Christina R.

AU - Pelc, Rebecca S.

AU - Speer, Scott D.

AU - Smith, Alexander R.Y.

AU - Goo, Leslie

AU - Platt, Derek J.

AU - Mascola, John R.

AU - Graham, Barney S.

AU - Mulligan, Mark J.

AU - Diamond, Michael S.

AU - Ledgerwood, Julie E.

AU - Pierson, Theodore C.

PY - 2016/8/9

Y1 - 2016/8/9

N2 - Recent epidemics of Zika virus (ZIKV) have been associated with congenital malformation during pregnancy and Guillain-Barré syndrome. There are two ZIKV lineages (African and Asian) that share >95% amino acid identity. Little is known regarding the ability of neutralizing antibodies elicited against one lineage to protect against the other. We investigated the breadth of the neutralizing antibody response following ZIKV infection by measuring the sensitivity of six ZIKV strains to neutralization by ZIKV-confirmed convalescent human serum or plasma samples. Contemporary Asian and early African ZIKV strains were similarly sensitive to neutralization regardless of the cellular source of virus. Furthermore, mouse immune serum generated after infection with African or Asian ZIKV strains was capable of neutralizing homologous and heterologous ZIKV strains equivalently. Because our study only defines a single ZIKV serotype, vaccine candidates eliciting robust neutralizing antibody responses should inhibit infection of both ZIKV lineages, including strains circulating in the Americas.

AB - Recent epidemics of Zika virus (ZIKV) have been associated with congenital malformation during pregnancy and Guillain-Barré syndrome. There are two ZIKV lineages (African and Asian) that share >95% amino acid identity. Little is known regarding the ability of neutralizing antibodies elicited against one lineage to protect against the other. We investigated the breadth of the neutralizing antibody response following ZIKV infection by measuring the sensitivity of six ZIKV strains to neutralization by ZIKV-confirmed convalescent human serum or plasma samples. Contemporary Asian and early African ZIKV strains were similarly sensitive to neutralization regardless of the cellular source of virus. Furthermore, mouse immune serum generated after infection with African or Asian ZIKV strains was capable of neutralizing homologous and heterologous ZIKV strains equivalently. Because our study only defines a single ZIKV serotype, vaccine candidates eliciting robust neutralizing antibody responses should inhibit infection of both ZIKV lineages, including strains circulating in the Americas.

UR - http://www.scopus.com/inward/record.url?scp=84989945183&partnerID=8YFLogxK

U2 - 10.1016/j.celrep.2016.07.049

DO - 10.1016/j.celrep.2016.07.049

M3 - Article

C2 - 27481466

AN - SCOPUS:84989945183

SN - 2211-1247

VL - 16

SP - 1485

EP - 1491

JO - Cell Reports

JF - Cell Reports

IS - 6

ER -

Broadly Neutralizing Activity of Zika Virus-Immune Sera Identifies a Single Viral Serotype

Abstract

Access to Document

Other files and links

Fingerprint

Cite this